General Information of Drug Formulation (ID: F21388)

Formulation Name
Topotecan 0.25 mg capsule
Company
Novartis Pharmaceuticals Corporation
Pharmaceutical Drug(s) in Formulation
Drug Name Drug ID Indication ICD 11 Status
Topotecan DMP6G8T Central nervous system neoplasm Approved
Pharmaceutical Excipient(s) in Formulation
Excipient Name Excipient ID PubChem CID Functional Classification
Eisenoxyd E00585 56841934 Colorant
Glyceryl monostearate E00310 24699 Emollient; Emulsifying agent; Emulsion stabilizing agent; Solubilizing agent; Surfactant; Viscosity-controlling agent
Titanium dioxide E00322 26042 Coating agent; Colorant; Opacifying agent